Liquid chromatography-mass spectrometry in in vitro drug metabolite screening
- PMID: 19059358
- DOI: 10.1016/j.drudis.2008.11.002
Liquid chromatography-mass spectrometry in in vitro drug metabolite screening
Abstract
A combination of high performance liquid chromatography (HPLC) and mass spectrometry (LC/MS) has proven its status as the most powerful analytical tool for screening and identifying drug metabolites in modern drug discovery. These techniques have become irreplaceable for drug metabolism laboratories, providing high amounts of information from a wide variety of samples. This review focuses on the most common and useful applications of these techniques when working on in vitro metabolism, more specifically with screening and identification of chemically stable or reactive metabolites formed via biotransformation reactions. Matching specific tasks and suitable instruments is a recurring consideration; for many reasons, the time-of-flight or orbitrap mass spectrometry provides clearly increased efficiency in metabolite profiling compared to other types of mass spectrometry.
Similar articles
-
Current and future trends in the application of HPLC-MS to metabolite-identification studies.Drug Discov Today. 2007 Mar;12(5-6):249-56. doi: 10.1016/j.drudis.2007.01.007. Epub 2007 Feb 8. Drug Discov Today. 2007. PMID: 17331890 Review.
-
Principles and applications of LC-MS in new drug discovery.Drug Discov Today. 2005 Oct 15;10(20):1357-67. doi: 10.1016/S1359-6446(05)03620-2. Drug Discov Today. 2005. PMID: 16253874 Review.
-
In vitro metabolite identification using fast gradient high performance liquid chromatography combined with tandem mass spectrometry.Rapid Commun Mass Spectrom. 2002;16(3):212-9. doi: 10.1002/rcm.556. Rapid Commun Mass Spectrom. 2002. PMID: 11803543
-
Recent advances in applications of liquid chromatography-tandem mass spectrometry to the analysis of reactive drug metabolites.Chem Biol Interact. 2009 Apr 15;179(1):25-37. doi: 10.1016/j.cbi.2008.09.014. Epub 2008 Sep 19. Chem Biol Interact. 2009. PMID: 18848531 Review.
-
Quantitative analysis of pharmacokinetic study samples by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS).Pharmazie. 1999 Sep;54(9):639-44. Pharmazie. 1999. PMID: 10522267 Review.
Cited by
-
Comparison of trapping profiles between d-peptides and glutathione in the identification of reactive metabolites.Toxicol Rep. 2015 Jul 9;2:1024-1032. doi: 10.1016/j.toxrep.2015.07.002. eCollection 2015. Toxicol Rep. 2015. PMID: 28962444 Free PMC article.
-
Characterization of Stable and Reactive Metabolites of the Anticancer Drug, Ensartinib, in Human Liver Microsomes Using LC-MS/MS: An in silico and Practical Bioactivation Approach.Drug Des Devel Ther. 2020 Nov 30;14:5259-5273. doi: 10.2147/DDDT.S274018. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 33299299 Free PMC article.
-
Piperazine ring toxicity in three novel anti-breast cancer drugs: an in silico and in vitro metabolic bioactivation approach using olaparib as a case study.Naunyn Schmiedebergs Arch Pharmacol. 2023 Jul;396(7):1435-1450. doi: 10.1007/s00210-023-02413-9. Epub 2023 Feb 4. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 36738368
-
Reactive intermediates in copanlisib metabolism identified by LC-MS/MS: phase I metabolic profiling.RSC Adv. 2019 Feb 21;9(11):6409-6418. doi: 10.1039/c8ra10322d. eCollection 2019 Feb 18. RSC Adv. 2019. PMID: 35517257 Free PMC article.
-
A sensitive and specific liquid chromatography-tandem mass spectrometry method for the determination of intracellular and extracellular uric acid.J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Jul 15;877(22):2032-8. doi: 10.1016/j.jchromb.2009.05.037. Epub 2009 May 27. J Chromatogr B Analyt Technol Biomed Life Sci. 2009. PMID: 19520625 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical